Patent Assignment
Reel/Frame 035435/0539
Assignment of Assignor's Interest
Recorded: 2015-04-17
Pages: 4
Assignee
BIODESIX, INC.
2970 WILDERNESS PLACE, BOULDER, COLORADO, 80301
Covered Property
(1)
Method for treating and identifying lung cancer patients likely to benefit from EGFR inhibitor and a monoclonal antibody HGF inhibitor combination therapy
Application:
14/678,428 →
Publication:
US 2015/0285817
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 7, 2015
From: HAN, MAY; KOMARNITSKY, PHILIP; GYURIS, JENO
To: AVEO PHARMACEUTICALS, INC.
Reel/Frame 036984/0459 →
Security Interest
Feb 23, 2018
From: BIODESIX, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 045022/0976 →
Release of Security Interest
Mar 19, 2021
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
To: BIODESIX, INC.
Reel/Frame 055657/0911 →